Eli Lilly and Company and Ajax Therapeutics, Inc. , a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), announced a definitive agreement for Lilly to acquire Ajax. Ajax's lead asset, AJ1-11095, is an investigational, once-daily oral, first-in-cla…
BioMarin Pharmaceutical Inc. said that it completed the previously announced agreement to acquire Amicus Therapeutics for $14.50 per share in an all-cash transaction for a total equity value of approximately $4.8 billion. "The completion of the Amicus acquisition advances BioMarin's strategy to strengthen and divers…
IMG Pharmaceutical Co., Ltd., a majority-owned subsidiary of IMG Japan, the Group's holding company, announced that it has entered into a definitive agreement to acquire Matsumoto Pharmaceutical Co., Ltd., a Japanese pharmaceutical manufacturer. IMG Medical Group operates an integrated healthcare platform across Asi…
HanchorBio, Inc. , a global clinical-stage biotechnology company advancing next-generation immunotherapies for immuno-oncology and immune-related diseases, announced it has selected Bloomberg to support strategic decision-making across portfolio planning, pipeline development, competitive monitoring, business developm…
Agilent Technologies Inc. announced a three-year strategic collaboration with OmixAI to advance next-generation precision medicine through AI-driven proteomics research, strengthening Agilent’s presence in fast-growing life sciences markets in Asia. The collaboration focuses on the joint development of automated sampl…
Dawn Medical Technologies, CBC Group's MedTech commercialization platform, announced the acquisition of a controlling interest in Pinnacle Health Equipment Joint Stock Company, one of Vietnam's largest and most established full-service MedTech distributors. This strategic transaction marks Dawn's entry into the fast-g…
OZMOSI, a leading provider of structured pharmaceutical development intelligence, announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD). This integration brings external clinical reality into internal R&a…
Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization ("CDMO"), and ENCell Co., Ltd, a Korea-based advanced biopharmaceutical CDMO, announced the signing of a Collaboration Agreement to establish a strategic manufacturing bridge between the United …
UCB (Euronext Brussels: UCB), a global biopharmaceutical company, announced that it has entered into a definitive agreement under which UCB would acquire Neurona Therapeutics, including lead asset NRTX-1001, adding to UCB's epilepsy portfolio. Neurona Therapeutics is a clinical-stage biotherapeutics company focused on…
Eli Lilly and Company and Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today announced a definitive agreement for Lilly to acquire Kelonia. Kelonia has developed a proprietary in vivo gene placement system (iGPS® ) that uses specially engineered lentiviral-based…
Page 11 of 37